Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medtech and consumer devices. Its platform uses radiofrequency technology, which enables the creation of sensors that are small enough to fit into wearable devices and other small form factors. The company develops Movano Ring that measures heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen saturation, steps, and calories, as well as incorporates women-centric features and design. It is also developing non-invasive continuous glucose monitoring and cuffless blood pressure monitoring features to its technology platform. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.
Website: movano.com


  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 0.0% (LTM)
  • Share price is 6 784.5% higher than minimum and 24.9% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (500.0x vs 0.0x)

Key Financials (Download financials)

Ticker: MOVE
Share price, USD:  (0.0%)18.12
year average price 10.15  


year start price 0.66 2025-06-13

min close price 0.54 2025-09-25

max close price 24.14 2026-05-21

current price 18.12 2026-06-12
Common stocks: 77 939 000

Dividend Yield:  0.0%
EV / Sales: 200.0x
Margin (EBITDA LTM / Revenue):

Target EV / EBITDA (hist percentile): 0.0x
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 1 412
Net Debt ($m): -18
EV (Enterprise Value): 1 394
EBITDA LTM (млн $): -44
Price to Book: -751.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2026-02-02newsfilecorp.com

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Movano Inc. (MOVE)

2025-11-27globenewswire.com

Halper Sadeh LLC Encourages MOVE and GIFI Shareholders to Contact the Firm to Discuss Their Rights

2025-10-08prnewswire.com

Movano Health Announces Reverse Stock Split

2025-08-28prnewswire.com

Movano Health Granted Listing Extension by Nasdaq

2025-08-22prnewswire.com

Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

2025-07-11prnewswire.com

Movano Health Plans to Timely Request a Hearing Before a Nasdaq Hearings Panel

2025-05-16prnewswire.com

Movano Health's Board of Directors Initiates Process to Maximize Shareholder Value

2025-01-08prnewswire.com

ITALIAN TRADE AGENCY TO HOST "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE

2025-01-07businesswire.com

Transforming Travel: AirAsia MOVE Partners with Antom for Seamless Payment Solutions

2024-12-13prnewswire.com

ERA REAL ESTATE LAUNCHES "MOVE UP" CAMPAIGN
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-14 2025-09-24 2024-11-14 2024-08-14 2024-05-17 2023-11-14 2023-08-14 2023-05-15 2022-11-14
acceptedDate 2025-11-14 16:20:57 2025-09-24 17:04:02 2025-04-09 17:09:07 2024-11-14 16:22:57 2024-08-14 16:06:00 2024-05-17 16:27:03 2024-04-29 16:15:22 2023-11-14 16:01:38 2023-08-14 16:32:44 2023-05-15 16:02:05 2023-03-30 16:02:16 2022-11-14 16:33:30 2022-03-30 16:01:50 2020-12-31 00:00:00
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 80 000 103 000 1M 50 000 0 852 000 0 0 0 0 0 0 0 0
costOfRevenue 280 000 362 000 3M 845 000 380 000 1M 158 000 40 000 37 000 0 134 000 0 74 000 13 000
grossProfit -200 000 -259 000 -2M -795 000 -380 000 -363 000 -158 000 -40 000 -37 000 0 -134 000 0 -74 000 -13 000
grossProfitRatio -2.5 -2.515 -15.9 0 -0.426 0 0 0 0
researchAndDevelopmentExpenses 1M 1M 11M 3M 3M 3M 17M 6M 4M 4M 19M 5M 13M 8M
generalAndAdministrativeExpenses 0 0 0 0 0 379 000 0 0 3213 3M 1927 4M 6M 3M
sellingAndMarketingExpenses 0 0 0 0 0 2M 0 0 3M 0 11M 0 0 0
sellingGeneralAndAdministrativeExpenses 1M 2M 11M 3M 3M 3M 13M 3M 3M 3M 11M 4M 6M 3M
otherExpenses 0 0 0 0 0 -3M 0 0 0 0 0 0 0 0
operatingExpenses 2M 3M 22M 7M 6M 5M 30M 9M 7M 7M 30M 9M 20M 11M
costAndExpenses 3M 3M 25M 7M 6M 7M 30M 9M 7M 7M 30M 9M 20M 11M
interestIncome 0 0 495 000 0 0 34 000 0 0 117 107 000 133 000 55 000 22 000 27 000
interestExpense 2M 0 0 0 0 0 0 0 117 000 -107 000 133 000 55 000 883 000 1M
depreciationAndAmortization 28 000 56 000 166 000 49 000 27 000 43 000 158 000 40 000 40 000 38 000 134 000 91 000 74 000 13 000
ebitda -2M -3M -24M -7M -6M -6M -29M -9M -7M -7M -30M -9M -21M -12M
ebitdaratio -31.225 -30.767 -146.6 0 -6.703 0 0 0 0
operatingIncome -3M -3M -24M -7M -6M -6M -30M -9M -7M -7M -30M -9M -20M -11M
operatingIncomeRatio -32.388 -31.65 -147.58 0 -6.754 0 0 0 0
totalOtherIncomeExpensesNet -1M 35 000 495 000 178 000 207 000 34 000 407 000 117 000 117 000 107 000 133 000 55 000 -2M -2M
incomeBeforeTax -4M -3M -24M -7M -6M -6M -29M -9M -7M -7M -30M -9M -22M -13M
incomeBeforeTaxRatio -50.363 -31.311 -144.02 0 -6.714 0 0 0 0
incomeTaxExpense 0 0 0 0 0 -276 0 -40 000 -40 000 -107 000 -133 000 -55 000 809 000 0
netIncome -4M -3M -24M -7M -6M -6M -29M -9M -7M -7M -30M -9M -23M -14M
netIncomeRatio -50.363 -31.311 -144.02 0 -6.714 0 0 0 0
eps -0.052 -0.41 -0.39 -1.06 -0.93 -0.1 -0.63 -0.18 -0.17 -0.19 -0.91 -0.26 -0.69 -0.44
epsdiluted -0.052 -0.41 -1.06 -0.93 -0.1 -0.18 -0.17 -0.19 -0.26
weightedAverageShsOut 78M 78M 60M 7M 7M 56M 46M 51M 43M 38M 33M 33M 33M 32M
weightedAverageShsOutDil 78M 78M 60M 7M 7M 56M 46M 51M 43M 38M 33M 33M 33M 32M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-04-09 2024-04-29 2023-03-30 2022-03-30 2020-12-31
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome 495 000 0 0 -861 000 -977 000
ebit -24M -29M -30M -21M -12M
nonOperatingIncomeExcludingInterest 0 -407 000 -133 000 1M 920 000
netIncomeFromContinuingOperations -24M -29M -30M -23M -13M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 -1M
netIncomeDeductions 0 0 133 000 2M 8M
bottomLineNetIncome -24M -29M -30M -24M -22M
epsDiluted -0.39 -0.63 -0.91 -0.69 -0.44

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-14 2025-09-24 2024-11-14 2024-08-14 2024-05-17 2023-11-14 2023-08-14 2023-05-15 2022-11-14
acceptedDate 2025-11-14 16:20:57 2025-09-24 17:04:02 2025-04-09 17:09:07 2024-11-14 16:22:57 2024-08-14 16:06:00 2024-05-17 16:27:03 2024-04-29 16:15:22 2023-11-14 16:01:38 2023-08-14 16:32:44 2023-05-15 16:02:05 2023-03-30 16:02:16 2022-11-14 16:33:30 2022-03-30 16:01:50 2020-12-31 00:00:00
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 2M 2M 8M 11M 17M 2M 6M 8M 14M 14M 11M 16M 18M 6M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0 822 000 16M 0
cashAndShortTermInvestments 2M 2M 8M 11M 17M 2M 6M 8M 14M 14M 11M 17M 34M 6M
netReceivables 0 52 000 52 000 233 000 233 000 514 000 450 000 250 000 271 000 289 000 0 379 000 166 000 500 000
inventory 2M 2M 2M 2M 2M 1M 1M 601 000 0 0 0 0 -166 000 0
otherCurrentAssets 390 000 246 000 362 000 476 000 798 000 326 000 442 000 657 000 1M 669 000 887 000 942 000 1M 0
totalCurrentAssets 5M 5M 10M 14M 20M 4M 9M 9M 16M 15M 12M 18M 35M 7M
propertyPlantEquipmentNet 592 000 666 000 213 000 237 000 272 000 299 000 589 000 363 000 404 000 418 000 443 000 460 000 529 000 38 000
goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
intangibleAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
goodwillAndIntangibleAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
longTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
taxAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentAssets 102 000 108 000 717 000 816 000 865 000 390 999 309 000 1M 1M 1M 1M 905 000 678 000 144 000
totalNonCurrentAssets 694 000 774 000 930 000 1M 1M 689 999 898 000 1M 1M 2M 2M 1M 1M 182 000
otherAssets 0 0 0 0 0 1 0 0 0 0 0 0 0 0
totalAssets 6M 6M 11M 15M 21M 5M 9M 11M 18M 17M 13M 19M 36M 7M
accountPayables 3M 3M 2M 2M 2M 4M 3M 2M 2M 540 000 557 000 621 000 311 000 246 000
shortTermDebt 0 226 000 0 102 000 117 000 175 000 0 204 000 206 000 209 000 0 216 000 0 248 000
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 8000 5000 36 000 20 000 0 251 000 1M 3M -206 000 0 0 0 0 0
otherCurrentLiabilities 4M 605 000 972 000 2M 2M 2M 762 000 214 000 3M 5M 984 000 4M 2M 290 000
totalCurrentLiabilities 7M 4M 3M 4M 3M 7M 6M 6M 5M 5M 5M 4M 3M 1M
longTermDebt 0 0 0 0 0 2000 0 69 121 000 168 000 0 258 000 0 11M
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherNonCurrentLiabilities 332 000 396 000 520 000 583 000 627 000 42 000 73 000 115 931 71 000 102 000 136 000 -408 000 317 000 3M
totalNonCurrentLiabilities 332 000 396 000 520 000 583 000 627 000 44 000 73 000 116 000 192 000 270 000 350 000 429 000 317 000 14M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 226 000 186 000 102 000 117 000 31 000 217 000 204 000 327 000 377 000 426 000 474 000 0 0
totalLiabilities 7M 4M 4M 5M 4M 7M 6M 6M 5M 6M 5M 5M 4M 15M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 33M
commonStock 10000 10000 10000 10000 10000 6000 6000 5000 5000 4000 3000 3000 3000 1000
retainedEarnings -161M -157M -148M -143M -136M -130M -124M -118M -109M -102M -95M -87M -65M -41M
accumulatedOtherComprehensiveIncomeLoss 0 0 0 0 0 -0 0 0 0 0 0 -5000 -11 000 -1000
othertotalStockholdersEquity 159M 158M 154M 153M 129M 123M 122M 113M 102M
totalStockholdersEquity -2M 2M 7M 10M 17M -1M 3M 5M 13M 11M 8M 15M 33M -8M
totalEquity -2M 2M 7M 10M 17M -1M 3M 5M 13M 11M 8M 15M 33M -8M
totalLiabilitiesAndStockholdersEquity 6M 6M 15M 21M 5M 11M 18M 17M 19M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 6M 6M 11M 15M 21M 5M 9M 11M 18M 17M 13M 19M 36M 7M
totalInvestments 0 0 0 0 0 0 0 0 0 0 0 822 000 16M 0
totalDebt 0 226 000 186 000 102 000 143 000 206 000 217 000 204 000 327 000 377 000 426 000 474 000 0 12M
netDebt -2M -2M -8M -11M -17M -2M -6M -7M -14M -14M -10M -15M -18M 6M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-04-09 2024-04-29 2023-03-30 2022-03-30 2020-12-31
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 52 000 0 0 0 0
otherReceivables 0 450 000 0 166 000 500 000
prepaids 28 000 399 000 0 0 691 000
totalPayables 2M 3M 557 000 311 000 246 000
otherPayables 0 0 0 0 0
accruedExpenses 235 000 550 000 3M 565 000 376 000
capitalLeaseObligationsCurrent 186 000 217 000 212 000 0 0
capitalLeaseObligationsNonCurrent 0 0 214 000 0 0
treasuryStock 0 0 0 0 0
additionalPaidInCapital 155M 128M 103M 98M 0
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-12-31 2020-12-31
symbol MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE MOVE
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2025-11-14 2025-09-24 2024-11-14 2024-08-14 2024-05-17 2023-11-14 2023-08-14 2023-05-15 2022-11-14 2022-08-15
acceptedDate 2025-11-14 16:20:57 2025-09-24 17:04:02 2025-04-09 17:09:07 2024-11-14 16:22:57 2024-08-14 16:06:00 2024-05-17 16:27:03 2024-04-29 16:15:22 2023-11-14 16:01:38 2023-08-14 16:32:44 2023-05-15 16:02:05 2023-03-30 16:02:16 2022-11-14 16:33:30 2022-08-15 16:07:14 2022-03-30 16:01:50 2020-12-31 00:00:00
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
netIncome -4M -3M -24M -7M -6M -6M -29M -9M -7M -7M -30M -9M -7M -22M -13M
depreciationAndAmortization 28 000 37 000 166 000 49 000 27 000 43 000 158 000 40 000 40 000 38 000 147 000 36 000 38 000 74 000 13 000
deferredIncomeTax 0 0 0 0 0 0 0 13 000 0 0 0 0 0 1M 947 000
stockBasedCompensation 0 780 000 3M 534 000 2M 617 000 3M 757 000 771 000 724 000 3M 797 000 761 000 2M 713 000
changeInWorkingCapital 186 000 -688 000 -3M 3M -4M 864 000 -269 000 1M -1M 257 000 2M 1M -374 000 1M -725 000
accountsReceivables 0 0 567 000 -331 000 290 000 41 000 427 000 21 000 18 000 0 0 0 0 0 0
inventory 6000 -221 000 -932 000 -969 000 0 50 000 -1M -21 000 -18 000 0 0 0 0 0 0
accountsPayables 71 000 266 000 -1M 364 000 -2M 865 000 3M 433 000 1M -53 000 246 000 -132 000 104 000 65 000 231 000
otherWorkingCapital 109 000 -733 000 -1M 4M -1M -92 000 -2M 760 000 -2M 53 000 2M 1M 0 1M -956 000
otherNonCashItems 2M 0 308 000 -2M 65 000 -188 000 237 000 -5000 -3000 -3000 134 000 5000 0 937 000 1M
netCashProvidedByOperatingActivities -2M -3M -23M -6M -8M -4M -26M -7M -8M -6M -25M -6M -6M -16M -11M
investmentsInPropertyPlantAndEquipment 0 0 -8000 3000 0 -6000 -64 000 -12 000 -26 000 -13 000 -105 000 -22 000 -20 000 -565 000 0
acquisitionsNet 0 0 0 0 0 0 0 0 0 0 0 0 0 16 134 0
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 -24M 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 16M 3M 5M 7M 0
otherInvestingActivites 0 0 0 0 0 0 0 0 0 0
netCashUsedForInvestingActivites 0 0 3000 0 -6000 -12 000 -26 000 -13 000 3M 5M
debtRepayment 2M 0 0 0 0 0 0 0 0 0
commonStockIssued 0 848 000 91 000 23M 164 000 282 000 8M 9M 2M 19 000
commonStockRepurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0 0
otherFinancingActivites 0 0 -15 000 15 000 164 000 -109 000 0 109 000 0 0
netCashUsedProvidedByFinancingActivities 2M 848 000 76 000 23M 164 000 173 000 8M 10M 2M 19 000
effectOfForexChangesOnCash 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
netChangeInCash -109 000 -2M 2M -6M 15M -4M -5M -7M 203 000 4M -7M -1M -1M 12M 1M
cashAtEndOfPeriod 2M 2M 8M 11M 17M 2M 6M 8M 14M 14M 11M 16M 17M 18M 6M
cashAtBeginningOfPeriod 2M 4M 6M 17M 2M 6M 11M 14M 14M 11M 18M 17M 18M 6M 4M
operatingCashFlow -2M -3M -23M -6M -8M -4M -26M -7M -8M -6M -25M -6M -6M -16M -11M
capitalExpenditure 0 0 -8000 3000 0 -6000 -64 000 -12 000 -26 000 -13 000 -105 000 -22 000 -20 000 -565 000 0
freeCashFlow -2M -3M -23M -6M -8M -4M -26M -7M -8M -6M -25M -6M -6M -17M -11M
link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link
filingDate 2025-04-09 2024-04-29 2023-03-30 2022-03-30 2020-12-31
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 0 0 15 829 -16 134 0
netCashProvidedByInvestingActivities -8000 -64 000 16M -17M 0
netDebtIssuance 0 0 0 0 12M
longTermNetDebtIssuance 0 0 0 0 12M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 24M 22M 2M 45M 676 000
netCommonStockIssuance 24M 22M 2M 45M 676 000
commonStockIssuance 24M 22M 2M 45M 676 000
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 0 0 0 0 -695 000
netCashProvidedByFinancingActivities 24M 22M 2M 45M 12M
incomeTaxesPaid 0 0 0 0 0
interestPaid 0 0 0 0 0

Earning call transcript

2024 q3
2024-11-14 ET (fiscal 2024 q3)
2024 q2
2024-08-14 ET (fiscal 2024 q2)
2024 q1
2024-05-15 ET (fiscal 2024 q1)
2023 q4
2024-04-10 ET (fiscal 2023 q4)
2023 q3
2023-11-15 ET (fiscal 2023 q3)
2023 q2
2023-08-15 ET (fiscal 2023 q2)
2023 q1
2023-05-15 ET (fiscal 2023 q1)
2022 q4
2023-03-20 ET (fiscal 2022 q4)
2022 q3
2022-11-14 ET (fiscal 2022 q3)
2022 q2
2022-08-15 ET (fiscal 2022 q2)
2022 q1
2022-05-15 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2026-03-24 ET
CORVEX, INC. ANNOUNCES ADDITIONAL DETAILS OF SPECIAL 35.8% STOCK DIVIDEND FOR SHAREHOLDERS OF RECORD ON MARCH 30, 2026
2026-03-19 ET
CORVEX ANNOUNCES CLOSING OF ALL-STOCK MERGER
2026-03-12 ET
Corvex Launches Secure Model Weights, Delivering Hardware-Enforced Protection for AI Inference on Third-Party Infrastructure
2026-03-03 ET
Corvex Among the First Companies to Achieve Verified Production Deployment of Confidential Computing for AI on NVIDIA HGX™ B200 Systems
2026-01-22 ET
Corvex Secures Long-Term NVIDIA H200 GPU Deployment with AI-driven Provider of High-Performance Battery Technologies to Support Production AI Workloads
2025-11-10 12:30 ET
CORVEX TO GO PUBLIC IN ALL-STOCK MERGER WITH MOVANO, CREATING A PURE-PLAY PLATFORM FOR SECURE AI INFRASTRUCTURE AND HIGH-PERFORMANCE INFERENCE
2025-10-08 12:30 ET
Movano Health Announces Reverse Stock Split
2025-08-28 ET
Movano Health Granted Listing Extension by Nasdaq
2025-07-11 ET
Movano Health Plans to Timely Request a Hearing Before a Nasdaq Hearings Panel
2025-05-23 ET
Movano Health Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
2025-05-16 ET
Movano Health's Board of Directors Initiates Process to Maximize Shareholder Value
2025-04-22 ET
Movano Health's Proprietary Cuffless Blood Pressure Device Once Again Achieves Accuracy Commensurate with the FDA's Requirements
2025-03-10 ET
Movano's Evie Ring Adds New Personalization and Trend Tracking to Support Women's Wellness Journey
2025-02-04 ET
Movano Health Commences Clinical Study with New Cuffless Blood Pressure Device
2025-01-08 ET
Movano Health Launches EvieAI Virtual Wellness Assistant
2025-01-02 ET
Movano Health Welcomes Dr. Shaheen Wirk to its Board of Directors
2024-12-02 ET
Movano Health Receives FDA Clearance for EvieMED Ring
2024-11-14 21:05 ET
Movano Health Reports Q3 2024 Financial Results and Provides Business Update
2024-11-07 13:00 ET
Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device
2024-11-06 13:00 ET
Movano Health to Report Third Quarter 2024 Financial Results on Thursday November 14, 2024
2024-11-04 13:00 ET
Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split
2024-11-04 13:00 ET
Movano Health Submits Response to FDA as Part of Final Review Phase for EvieMED
2024-10-31 12:30 ET
Movano Health Opens Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split
2024-10-30 13:00 ET
Evie Ring Announces Brand Partnership with Lifestyle Content Creator Heidi D'Amelio
2024-10-25 13:00 ET
Movano Health Announces Reverse Stock Split
2024-10-24 12:00 ET
Movano Health Plans Response Submission to FDA Next Week as Part of EvieMED Final Review Phase
2024-10-10 12:00 ET
Movano Health Provides Update on FDA Review of EvieMED Ring
2024-09-17 12:00 ET
Evie, Movano Health's Smart Ring for Women, is Back In Stock with Key Upgrades
2024-09-03 12:00 ET
Movano Health Advances to Final Phase of FDA Review Process for EvieMED Ring
2024-08-14 20:05 ET
Movano Health Reports Q2 2024 Financial Results and Provides Business Update
2024-08-05 13:00 ET
Movano Health Provides Progress Update on EvieMED Regulatory Filing
2024-08-05 13:00 ET
Movano Health to Report Second Quarter 2024 Financial Results on Wednesday August 14, 2024
2024-06-28 13:00 ET
Movano Health Announces Dr. Fatima Rodriguez Joining July 11 Virtual Event
2024-06-13 13:00 ET
Movano Health Applies Advanced AI through Deep Learning to Deliver Improved Accuracy of Heart Rate in Motion
2024-06-10 13:00 ET
MIT Selects Movano Health for Groundbreaking Study on Long COVID and Chronic Lyme Disease
2024-05-15 20:05 ET
Movano Health Reports Q1 2024 Financial Results and Provides Business Update
2024-05-09 12:00 ET
Movano Health Submits Exemplary Sp02 Clinical Trial Results in Key Step Towards FDA 510(k) Clearance Decision
2024-05-06 21:00 ET
Movano Health to Report First Quarter 2024 Financial Results on Wednesday May 15, 2024
2024-04-05 12:00 ET
Movano Health Closes $24 Million Private Placement
2024-04-05 12:00 ET
Movano Health Closes $24 Million Private Placement
2024-04-04 20:30 ET
Movano Health Reports 2023 Financial Results and Provides Business Update
2024-04-03 11:00 ET
BestGrowthStocks.Com Issues Comprehensive Evaluation of Movano Inc.
2024-04-02 21:01 ET
Movano Health Announces $24 Million Private Placement
2024-04-02 21:01 ET
Movano Health Announces $24 Million Private Placement
2024-04-02 21:00 ET
Movano Health Secures Strategic Investment from Tier-One Multi-Billion Dollar Medical Device Company
2024-04-02 20:05 ET
Movano Health to Report Fourth Quarter 2023 Financial Results on Thursday, April 4, 2024
2024-03-14 22:31 ET
Evie Ring's Pulse Oximeter Exceeds FDA Accuracy Guidelines in Movano Health's Second Hypoxia Trial
2024-01-22 13:00 ET
Movano Health Announces Evie Rings Now Shipping
2024-01-09 13:00 ET
Movano Health and ams OSRAM Collaborate to Deliver Accurate Lifestyle Monitoring Solutions for Women
2024-01-08 12:00 ET
Evie, the First Women-Focused Health Ring, Takes 'Smart' to a New Level
2023-12-18 13:00 ET
Movano Health Announces HSA/FSA Eligibility for its Women First Wearable, The Evie Ring
2023-12-12 17:00 ET
Movano Health Announces Blood Pressure Partnership Forum Following Significant Response to Groundbreaking Accuracy Achievement
2023-12-05 13:00 ET
Movano Health's Women-First Wearable, the Evie Ring, Receives 2024 CES Innovation Award
2023-11-29 13:00 ET
Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring as well as Cuffless Blood Pressure Milestone Achievement
2023-11-29 ET
Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring as well as Cuffless Blood Pressure Milestone Achievement
2023-11-20 13:00 ET
Evie, the Smart Ring for Women from Movano Health, Available for Order Today
2023-11-17 15:09 ET
Movano Health Announces Closing of $4.1 Million Public Offering Including Full Exercise of Over-Allotment Option
2023-11-17 ET
Movano Health Announces Closing of $4.1 Million Public Offering Including Full Exercise of Over-Allotment Option
2023-11-15 11:02 ET
Movano Health Provides Business Update and Reports Third Quarter 2023 Financial Results
2023-11-15 11:00 ET
Movano Health Prices $3.6 Million Public Offering
2023-11-15 ET
Movano Health Prices $3.6 Million Public Offering
2023-11-14 21:15 ET
Movano Inc. to Report Third Quarter 2023 Financial Results on Wednesday, November 15, 2023
2023-11-14 21:06 ET
Movano Health Announces Proposed Public Offering
2023-11-03 20:05 ET
Movano Inc. to Report Third Quarter 2023 Financial Results Tuesday, November 14, 2023
2023-10-31 12:00 ET
Movano Health's Proprietary Chip and Prototype Achieves Accuracy Commensurate with the FDA's Requirements for Blood Pressure Monitoring
2023-10-30 12:00 ET
Movano Health to Launch the Evie Ring on November 20
2023-09-12 13:00 ET
Evie Ring Welcomes Cardiologist and Stanford University Associate Professor Dr. Fátima Rodriguez to its Medical Advisory Board
2023-08-30 13:00 ET
Movano Health, Maker of the Evie Ring, Selects Jay Group as its Fulfillment Provider in Preparation for its Commercial Launch
2023-08-14 20:05 ET
Movano Health Provides Business Update and Reports Second Quarter 2023 Financial Results
2023-08-10 13:00 ET
Evie Ring Establishes Medical Advisory Board Furthering its Commitment to Bringing a Medical-Grade Wearable to Women
2023-08-08 20:30 ET
Movano Inc. to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
2023-08-03 13:00 ET
Movano Health Achieves Major Milestone with First FDA Filing for Evie Ring's Pulse Oximeter
2023-06-15 20:05 ET
Movano Health Announces Closing of $9.2 Million Public Offering Including Full Exercise of Over-Allotment Option
2023-06-15 ET
Movano Health Announces Closing of $9.2 Million Public Offering Including Full Exercise of Over-Allotment Option
2023-06-13 12:00 ET
Movano Health Prices $8.0 Million Public Offering
2023-06-13 ET
Movano Health Prices $8.0 Million Public Offering
2023-06-12 20:05 ET
Movano Health Announces Proposed Public Offering
2023-05-15 12:30 ET
Movano Health Provides Business Update and Reports First Quarter 2023 Financial Results
2023-04-24 13:00 ET
Movano Inc. to Report First Quarter 2023 Financial Results on Monday, May 15, 2023
2023-03-20 12:30 ET
Movano Health Provides Business Update and Reports Fourth Quarter 2022 Financial Results
2023-03-14 13:00 ET
Movano Health Awarded Three New Core Patents Validating its Cutting-Edge Approach to Radio Frequency-Enabled Glucose and Blood Pressure Monitoring
2023-03-07 14:00 ET
What Women Want: Accuracy is Critical to Future Wearable Use
2023-03-07 ET
What Women Want: Accuracy is Critical to Future Wearable Use
2023-02-23 14:00 ET
Movano Inc. to Report Fourth Quarter 2022 Financial Results on Monday, March 20, 2023
2023-02-06 14:00 ET
Movano Health Completes $7.5 Million Public Offering
2023-02-06 ET
Movano Health Completes $7.5 Million Public Offering
2023-01-27 13:00 ET
Movano Health Prices $6.5 Million Public Offering
2023-01-27 ET
Movano Health Prices $6.5 Million Public Offering
2023-01-26 21:03 ET
Movano Health Announces Proposed Public Offering
2023-01-17 14:00 ET
Movano Health's Evie Ring Wins 10 "Best of CES 2023" Awards
2022-12-28 12:00 ET
Movano Health Unveils Evie: First Medical Grade Smart Ring Designed Uniquely for Women
2022-12-28 ET
Movano Health Unveils Evie: First Medical Grade Smart Ring Designed Uniquely for Women
2022-12-14 14:00 ET
Movano Health On Track to File First FDA Submission for its Smart Ring's SpO2 and Heart Rate Data Following Successful Pivotal Hypoxia Trial
2022-12-13 14:00 ET
Movano Health Announces Launch of Smart Ring Beta Program with Novant Health
2022-11-16 14:00 ET
Movano Health to Participate in Bernstein CGM Disruptors Conference, BTIG Digital Health Forum and Benchmark Discovery Conference
2022-11-14 21:30 ET
Movano Health Provides Business Update and Reports Third Quarter 2022 Financial Results
2022-11-01 20:30 ET
Movano Inc. to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
2022-08-15 20:30 ET
Movano Inc. Provides Business Update and Reports Second Quarter 2022 Financial Results
2022-08-15 20:30 ET
Movano Announces Beta Program with Stanford University to Advance the Development of Comprehensive Health Data Monitoring for its Wearable Ring Solution
2022-08-11 13:00 ET
Movano Expands Go-To-Market Team with Vice President of UX and UI and Vice President of Digital Marketing and Growth
2022-08-09 13:00 ET
Movano to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022
2022-08-09 13:00 ET
Movano Ring Exceeds Accuracy Targets for SpO2 and Heart Rate Monitoring in Initial Hypoxia Study; Company Eyes FDA Submission
2022-05-12 20:30 ET
Movano Successfully Completes Functional Testing of Smallest Ever Custom mmWave Sensor Designed for Non-Invasive Glucose and Cuffless Blood Pressure Monitoring
2022-05-12 20:30 ET
Movano Inc. Provides Business Update and Reports First Quarter 2022 Financial Results
2022-05-03 13:00 ET
Movano Joins Innovators' Network at American Heart Association Center for Health Technology & Innovation
2022-04-22 20:30 ET
Movano to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
2022-04-18 13:00 ET
Movano Hires Chief Marketing Officer to Implement Its Multi-Channel Marketing Strategy for the Movano Ring and Future Medical Devices
2022-04-18 13:00 ET
Movano Welcomes Nan Kirsten Forte, a Pioneer and Innovator in Digital Health, as Its Newest Board Member
2022-03-24 20:30 ET
Movano Inc. Provides Business Update and Reports Fourth Quarter 2021 Financial Results
2022-03-10 21:00 ET
Movano to Report Fourth Quarter 2021 Financial Results on Thursday, March 24, 2022
2022-02-17 14:00 ET
Movano Completes its Second Glucose Pilot Study
2022-02-15 14:00 ET
Movano Announces Two Key Hires to Further Its Go-To-Market Strategy for the Movano Ring and Future Medical Devices
2022-02-07 14:00 ET
Movano to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
2022-01-27 14:00 ET
Movano Strengthens Intellectual Property for its Non-Invasive Sensor Technology with Three New U.S. Patents
2022-01-10 14:00 ET
Movano to Participate in 24th Annual Needham Virtual Growth Conference
2022-01-03 14:00 ET
Movano Completes Blood Pressure Study with 110 Participants
2021-12-27 12:00 ET
Movano Unveils Smart Ring Designed for Women Seeking More Approachable Health Insights
2021-11-11 21:30 ET
Movano Inc. Provides Business Update and Reports Third Quarter 2021 Financial Results
2021-11-09 21:30 ET
Movano Inc. to Participate in Bernstein CGM Disruptors Conference on Friday, November 19, 2021
2021-10-14 20:30 ET
Movano Inc. to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021
2021-08-12 20:30 ET
Movano Inc. Provides Business Update and Reports Second Quarter 2021 Financial Results
2021-07-14 20:30 ET
Movano Inc. to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021
2021-07-06 13:00 ET
Movano Conducts IRB-Approved Clinical Study with Prototype Blood Pressure Device
2021-06-08 18:00 ET
Movano Inc. Set to Join Russell Microcap Index
2021-05-13 20:30 ET
Movano Inc. Provides Business Update and Reports First Quarter 2021 Financial Results
2021-04-21 20:30 ET
Movano Inc. to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
2021-03-25 20:30 ET
Movano Inc. Appoints Medtech Industry Veteran John Mastrototaro, PhD, as CEO
2021-03-25 20:05 ET
Movano Inc. Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option
2021-03-23 12:00 ET
Movano Inc. Prices $42.5 Million Public Offering of Common Stock

SEC forms

Show financial reports only

SEC form 10
2026-03-30 23:43 ET
Movano Inc. published news for 2025 q4
SEC form 8
2025-12-19 23:38 ET
Movano Inc. published news for 2025 q3
SEC form 8
2025-12-19 23:38 ET
Movano Inc. published news for 2025 q3
SEC form 8
2025-12-19 23:38 ET
Movano Inc. published news for 2025 q3
SEC form 10
2025-11-14 16:20 ET
Movano Inc. reported for 2025 q3
SEC form 10
2025-09-24 21:04 ET
Movano Inc. reported for 2025 q2
SEC form 10
2025-09-24 21:02 ET
Movano Inc. reported for 2025 q1
SEC form 8
2025-08-28 20:36 ET
Movano Inc. published news for 2025 q2
SEC form 8
2025-08-28 20:36 ET
Movano Inc. published news for 2025 q2
SEC form 8
2025-06-25 21:12 ET
Movano Inc. published news for 2025 q1
SEC form 8
2025-06-25 21:12 ET
Movano Inc. published news for 2025 q1
SEC form 8
2025-05-19 12:48 ET
Movano Inc. published news for 2025 q1
SEC form 10
2025-04-09 21:09 ET
Movano Inc. reported for 2024 q4
SEC form 10
2025-04-09 00:00 ET
Movano Inc. reported for 2024 q4
SEC form 10
2024-11-14 16:22 ET
Movano Inc. reported for 2024 q3
SEC form 8
2024-11-14 00:00 ET
Movano Inc. published news for 2024 q3
SEC form 8
2024-11-14 00:00 ET
Movano Inc. reported for 2024 q3
SEC form 10
2024-11-14 00:00 ET
Movano Inc. reported for 2024 q3
SEC form 8
2024-08-14 16:13 ET
Movano Inc. published news for 2024 q2
SEC form 8
2024-08-14 16:13 ET
Movano Inc. reported for 2024 q2
SEC form 10
2024-08-14 16:06 ET
Movano Inc. reported for 2024 q2
SEC form 10
2024-08-14 00:00 ET
Movano Inc. reported for 2024 q2
SEC form 10
2024-05-17 00:00 ET
Movano Inc. reported for 2024 q1
SEC form 8
2024-05-15 00:00 ET
Movano Inc. reported for 2024 q1
SEC form 8
2024-05-15 00:00 ET
Movano Inc. published news for 2024 q1
SEC form 10
2024-04-16 00:00 ET
Movano Inc. reported for 2023 q4
SEC form 8
2024-04-04 00:00 ET
Movano Inc. published news for 2024 q1
SEC form 8
2024-04-04 00:00 ET
Movano Inc. published news for 2024 q1
SEC form 8
2023-11-15 00:00 ET
Movano Inc. reported for 2023 q3
SEC form 10
2023-11-14 00:00 ET
Movano Inc. reported for 2023 q3
SEC form 10
2023-08-14 00:00 ET
Movano Inc. reported for 2023 q2
SEC form 8
2023-08-14 00:00 ET
Movano Inc. reported for 2023 q2
SEC form 10
2023-05-15 00:00 ET
Movano Inc. reported for 2023 q1
SEC form 8
2023-05-15 00:00 ET
Movano Inc. reported for 2023 q1
SEC form 10
2023-03-30 16:02 ET
Movano Inc. reported for 2022 q4
SEC form 10
2023-03-30 00:00 ET
Movano Inc. reported for 2022 q4
SEC form 6
2023-03-20 08:51 ET
Movano Inc. reported for 2022 q4
SEC form 8
2023-03-20 00:00 ET
Movano Inc. reported for 2022 q4
SEC form 6
2023-01-31 17:01 ET
Movano Inc. published news for 2022 q4
SEC form 6
2022-11-14 16:46 ET
Movano Inc. reported for 2022 q3
SEC form 10
2022-11-14 16:33 ET
Movano Inc. reported for 2022 q3
SEC form 8
2022-11-14 00:00 ET
Movano Inc. reported for 2022 q3
SEC form 10
2022-11-14 00:00 ET
Movano Inc. reported for 2022 q3
SEC form 6
2022-08-15 17:22 ET
Movano Inc. reported for 2022 q2
SEC form 10
2022-08-15 16:07 ET
Movano Inc. reported for 2022 q2
SEC form 8
2022-08-15 00:00 ET
Movano Inc. reported for 2022 q2
SEC form 10
2022-08-15 00:00 ET
Movano Inc. reported for 2022 q2
SEC form 6
2022-06-22 16:10 ET
Movano Inc. published news for 2022 q1
SEC form 10
2022-05-12 16:49 ET
Movano Inc. reported for 2022 q1
SEC form 6
2022-05-12 16:38 ET
Movano Inc. published news for 2022 q1
SEC form 8
2022-05-12 00:00 ET
Movano Inc. reported for 2022 q1
SEC form 10
2022-05-12 00:00 ET
Movano Inc. reported for 2022 q1
SEC form 6
2022-04-28 16:07 ET
Movano Inc. published news for 2022 q1
SEC form 6
2022-04-18 16:23 ET
Movano Inc. published news for 2022 q1
SEC form 6
2022-03-30 16:18 ET
Movano Inc. published news for 2021 q4
SEC form 10
2022-03-30 16:01 ET
Movano Inc. published news for 2021 q4
SEC form 8
2022-03-30 00:00 ET
Movano Inc. published news for 2021 q4
SEC form 10
2022-03-30 00:00 ET
Movano Inc. published news for 2021 q4
SEC form 10
2021-11-12 16:06 ET
Movano Inc. published news for 2021 q3
SEC form 6
2021-11-12 08:30 ET
Movano Inc. published news for 2021 q3
SEC form 10
2021-11-12 00:00 ET
Movano Inc. published news for 2021 q3
SEC form 8
2021-11-12 00:00 ET
Movano Inc. published news for 2021 q3
SEC form 10
2021-08-12 17:28 ET
Movano Inc. published news for 2021 q2
SEC form 6
2021-08-12 16:47 ET
Movano Inc. published news for 2021 q2
SEC form 10
2021-08-12 00:00 ET
Movano Inc. published news for 2021 q2
SEC form 10
2021-05-14 00:00 ET
Movano Inc. published news for 2021 q1
SEC form 10
2021-05-13 20:34 ET
Movano Inc. published news for 2021 q1
SEC form 6
2021-05-13 16:37 ET
Movano Inc. published news for 2021 q1
SEC form 6
2021-03-25 16:50 ET
Movano Inc. published news for 2020 q4